Around 500 Sun Pharma medical representatives, previously employed by Ranbaxy prior to the acquisition by Sun Pharma, are planning a nationwide strike in India to protest unpaid salaries, travel expenses and changes in paid-leave policies.
The disgruntled sales reps' complaints will now be heard the Bombay High Court.
The $3.2 billion acquisition, announced in April 2014, has led to complexiities in merging the two companies due to the large size of both drugmakers. In June of last year, Sun Pharma announced the release of 18 top execs previously employed by its former rival, Ranbaxy.
Pressure placed on India sales reps has been under the spotlight recently. Last month, following the suicide of an Abbott Labs sales rep in India, 250 Abbott drug reps in India walked off the job for a day, protesting what some called the company’s overly aggressive sales policies.
Read the Business Standard article